A randomized, open-label study of the renal safety of intravenous Bondronat in patients with metastatic bone disease from breast cancer.
Phase of Trial: Phase II
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Ibandronic acid (Primary)
- Indications Advanced breast cancer; Cancer metastases
- Focus Adverse reactions
- Sponsors Roche
- 16 Jul 2008 Status changed from in progress to completed, from Roche record.
- 20 Jun 2006 New trial record.